Electromyography EMG Electrode Market Report 2024

The electromyography EMG electrode market size has grown strongly in recent years. It will grow from $0.85 billion in 2023 to $0.92 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth observed during the historic period can be attributed to several factors, the increasing elderly population, simplified regulatory processes for medical devices, expansion of clinical applications, the rise of telemedicine, and growing demand for portable and user-friendly EMG devices.

The electromyography EMG electrode market size is expected to see strong growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth during the forecast period can be attributed to several factors, the rising prevalence of neuromuscular disorders, increased awareness and improved access to healthcare, higher healthcare spending, greater use of EMG for injury prevention, and the growth of telemedicine and remote patient monitoring. Key trends expected to influence this period include advancements in EMG technology, integration of EMG with other diagnostic tools, incorporation of EMG sensors into wearable devices, development of advanced diagnostic tools, and enhanced training programs for healthcare professionals.

The increasing prevalence of neurological disorders is expected to drive the growth of the electromyography (EMG) electrode market. Neurological disorders affect the nervous system, including the brain, spinal cord, and nerves, leading to a range of physical, cognitive, and emotional symptoms. The rise in these disorders is linked to an aging population, greater exposure to risk factors such as pollution and lifestyle changes, and enhanced diagnostic capabilities. EMG electrodes are crucial for diagnosing and monitoring these disorders as they record electrical activity in muscles, which helps detect nerve dysfunction and muscle abnormalities. For instance, the World Federation of Neurology reported in October 2023 that over 40% of the global population suffers from some neurological condition, with the burden expected to nearly double by 2050. The global death toll from stroke is anticipated to rise by 50%, reaching 9.7 million deaths annually by 2050. Consequently, the growing prevalence of neurological disorders is fueling the expansion of the EMG electrode market.

Key players in the EMG electrode market are focusing on developing advanced products to maintain their competitive edge. An example is the advanced neuromuscular monitoring electrodes, which are designed to assess and monitor electrical activity and muscle function at the neuromuscular junction. For example, in October 2022, Nihon Kohden Corporation, a Japan-based medical device manufacturer, introduced the Smart Cable NMT Pod and Disposable Electrode. This new device enhances neuromuscular blockade monitoring during surgeries by providing a more accurate and automated method for assessing paralysis levels compared to traditional acceleromyography (AMG) techniques. The Smart Cable NMT Pod uses EMG to capture electrical signals from muscle tissues in response to peripheral nerve stimulation, offering precise measurements of neuromuscular activity.

In March 2023, Graham Partners Inc., a US-based investment firm, acquired Rhythmlink International LLC for an undisclosed amount. This acquisition aims to expand Graham Partners' portfolio, strengthen its market position, and enhance its capabilities in healthcare innovation and medical devices. Rhythmlink International LLC, a US-based company, specializes in providing electromyography electrodes.

Major companies operating in the electromyography emg electrode market are Nihon Kohden Corporation, Nissha Co Ltd, Bittium Corporation, Ambu A/S, Natus Medical Incorporated, Contec Medical Systems Co. Ltd, Neurosoft Ltd., Compumedics Limited, EB Neuro S.p.A., Inomed Medizintechnik GmbH, Technomed, Rhythmlink International LLC, BTS S.p.A, Cadwell Industries Inc., Thought Technology Ltd., Bio-Medical Instruments, Spes Medica Srl, BioRESEARCH Associates Inc., Clarity Medical Pvt. Ltd., DEYMED Diagnostic sro, Noraxon U.S.A. Inc.

North America was the largest region in the electromyography (EMG) electrode market in 2023. The regions covered in the electromyography emg electrode market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electromyography emg electrode market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An electromyography (EMG) electrode is a device used to detect and record electrical activity from skeletal muscles. It can be either surface electrodes placed on the skin or needle electrodes inserted directly into the muscle. These electrodes are crucial for diagnosing neuromuscular disorders, evaluating muscle function, and guiding treatment.

The main types of EMG electrodes include metal electrodes, non-metal electrodes, disposable electrodes, and reusable electrodes. Metal electrodes are conductors made of metal that establish electrical contact with non-metallic components of a circuit, such as electrolytes, semiconductors, or other metals. EMG electrodes are used across various age groups, including pediatric, adult, and geriatric patients. They are distributed through direct sales, retail pharmacies, and online pharmacies, and are utilized in settings such as hospitals, medical centers, specialty clinics, rehabilitation centers, and diagnostic centers.

The electromyography EMG electrode market research report is one of a series of new reports that provides electromyography EMG electrode market statistics, including electromyography EMG electrode industry global market size, regional shares, competitors with an electromyography EMG electrode market share, detailed electromyography EMG electrode market segments, market trends and opportunities, and any further data you may need to thrive in the electromyography EMG electrode industry. This electromyography EMG electrode market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electromyography EMG electrode market consists of sales of adhesive EMG electrodes, reusable surface electrodes, disposable surface electrodes, and bipolar needle electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.